Entero Therapeutics Inc. (ENTO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entero Therapeutics Inc.

    NASDAQ: ENTO · Real-Time Price · USD
    4.64
    0.35 (8.16%)
    At close: Oct 02, 2025, 1:25 PM

    Entero Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 29.27K 106.21K 537.4K
    Gross Profit
    		 n/a -29.27K -106.21K -537.4K
    Operating Income
    		 -15.62K -15.77M -12.68M -59.06M
    Interest Income
    		 n/a 2.53K 8.41K 1.17K
    Pretax Income
    		 -15.62K -15.79M -14.63M -58.54M
    Net Income
    		 -18.06M -15.79M -14.63M -58.54M
    Selling & General & Admin
    		 14.72K 10.74M 11.99M 18.38M
    Research & Development
    		 903.94 5.03M 691.26K 38.32M
    Other Expenses
    		 -0.00 n/a n/a 529.1K
    Operating Expenses
    		 15.62K 15.77M 12.68M 56.7M
    Interest Expense
    		 n/a 22.46K 15.88K 11.23K
    Selling & Marketing Expenses
    		 156K n/a n/a n/a
    Cost & Expenses
    		 15.62K 15.77M 12.68M 56.7M
    Income Tax Expense
    		 -0.00 n/a 126.56K 26.52M
    Shares Outstanding (Basic)
    		 4.65M 336.34K 35.91K 2.13K
    Shares Outstanding (Diluted)
    		 3.43M 336.34K 35.91K 2.13K
    EPS (Basic)
    		 -3.88 -46.96 -407.37 -27.54K
    EPS (Diluted)
    		 -5.26 -46.96 -407.37 -27.54K
    EBITDA
    		 -15.61K -15.74M -14.51M -57.99M
    EBIT
    		 -15.62K -15.77M -14.61M -58.53M
    Depreciation & Amortization
    		 48.95K 29.27K 29.27K 542.25K

    Add to Watchlist